Up until just a couple years ago, an 85-year-old patient presenting with gradual, amnestic memory loss was almost automatically presumed…
It’s an era of breakthroughs in Alzheimer’s research, yet for many clinicians, it’s also a time of profound uncertainty. We…
Things are changing quickly in the Alzheimer’s space. We now have biomarkers that can reasonably approximate the degree of amyloid…
The US Preventive Services Task Force (USPSTF) concluded back in 2000 that there is insufficient evidence to recommend for or…
There is a growing push to change how we define Alzheimer’s disease from what was historically a clinically defined syndrome…